Literature DB >> 11383718

Loss of locomotor sensitisation in response to morphine in D1 receptor deficient mice.

A Becker1, G Grecksch, J Kraus, B Peters, H Schroeder, S Schulz, V Höllt.   

Abstract

Mice lacking D1 receptors were used to study the role of these receptors in morphine-induced antinociception and locomotor sensitisation. In the hot-plate test D1 receptor deficient (-/-) and wild-type (+/+) mice showed similar reaction times under basal conditions. A single injection of 1.25 mg/kg and 2.5 mg/kg morphine resulted in a stronger antinociceptive response in D1 receptor deficient mice than in wild-type animals. Tolerance to the analgesic effect did not develop in both groups of animals when 12.5 mg/kg morphine was chronically applied twice daily for 13 days. There was no change in basal locomotor activity between saline-injected wild-type and D1 receptor deficient mice. After chronic treatment wild-type mice showed a continuous increase in locomotor activity, indicating the development of sensitisation. In contrast, a subchronic administration of morphine did not change locomotor activity in mutant mice. The lack of the development of locomotor sensitisation in D1 deficient mice was associated with reduced levels of immunoreactive mu opioid receptors in dorsal striatal patches as compared to wild-type mice. In contrast, no change in the distribution of immunoreactive mu receptors could be detected in areas related to pain pathways such as the spinal cord. Taken together, these results suggest an involvement of D1 receptors in morphine-induced locomotor activity and analgesia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11383718     DOI: 10.1007/s002100100404

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice.

Authors:  Nikhil M Urs; Tanya L Daigle; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2010-10-27       Impact factor: 7.853

2.  Heteromers of μ opioid and dopamine D1 receptors modulate opioid-induced locomotor sensitization in a dopamine-independent manner.

Authors:  Yi-Min Tao; Chuan Yu; Wei-Sheng Wang; Yuan-Yuan Hou; Xue-Jun Xu; Zhi-Qiang Chi; Yu-Qiang Ding; Yu-Jun Wang; Jing-Gen Liu
Journal:  Br J Pharmacol       Date:  2017-07-18       Impact factor: 8.739

3.  Lack of genotype effect on D1, D2 receptors and dopamine transporter binding in triple MOP-, DOP-, and KOP-opioid receptor knockout mice of three different genetic backgrounds.

Authors:  Ji-Hoon Yoo; Alexis Bailey; Micheal Ansonoff; John E Pintar; Audrey Matifas; Brigitte L Kieffer; Ian Kitchen
Journal:  Synapse       Date:  2010-07       Impact factor: 2.562

4.  Evidence that behavioral phenotypes of morphine in β-arr2-/- mice are due to the unmasking of JNK signaling.

Authors:  Nitish Mittal; Miao Tan; Onyemachi Egbuta; Nina Desai; Cynthia Crawford; Cui-Wei Xie; Christopher Evans; Wendy Walwyn
Journal:  Neuropsychopharmacology       Date:  2012-04-11       Impact factor: 7.853

5.  Functional characterization of G-protein-coupled receptors: a bioinformatics approach.

Authors:  L Tovo-Rodrigues; A Roux; M H Hutz; L A Rohde; A S Woods
Journal:  Neuroscience       Date:  2014-07-02       Impact factor: 3.590

6.  Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice.

Authors:  Sarah Jane Harrison; José N Nobrega
Journal:  Psychopharmacology (Berl)       Date:  2008-12-19       Impact factor: 4.530

7.  Interactive effects of morphine and dopaminergic compounds on spatial working memory in rhesus monkeys.

Authors:  Jian-Hong Wang; Joshua Dominie Rizak; Yan-Mei Chen; Liang Li; Xin-Tian Hu; Yuan-Ye Ma
Journal:  Neurosci Bull       Date:  2013-01-30       Impact factor: 5.203

8.  Biological Significance of GPCR Heteromerization in the Neuro-Endocrine System.

Authors:  Maud Kamal; Ralf Jockers
Journal:  Front Endocrinol (Lausanne)       Date:  2011-02-01       Impact factor: 5.555

9.  The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs.

Authors:  Thibaut Laboute; Jorge Gandía; Julie Le Merrer; Jérôme Aj Becker; Lucie P Pellissier; Yannick Corde; Florian Rebeillard; Maria Gallo; Christophe Gauthier; Audrey Léauté; Jorge Diaz; Anne Poupon; Brigitte L Kieffer
Journal:  Elife       Date:  2020-01-31       Impact factor: 8.140

Review 10.  Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic Animals.

Authors:  Chloe J Jordan; Zheng-Xiong Xi
Journal:  Front Neurosci       Date:  2022-01-12       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.